My initial reactions on the JV were more negative. Personally think that management should focus on expanding their core business, especially ensuring execution of their business in China market. I also think that stem cell banking business seems to be a stretch from their current business.

However, the investment is only 2.5 mil. So it does not warrant any action at the moment. I am keeping faith with the management that they know what they are doing.